Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Fusion Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q4 2021
- Shares held
- 28.2M
- +550.8K (+2.0%) vs. Q4 2021
- Total value
- $219.1M
- +$103.5M (+89.6%) vs. Q4 2021
- New holders
- 0
- 4 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Portfolios Advisors | 30 | $233 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 850 | $7.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 875 | $7.16K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4,352 | $34.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 8,253 | $64.0K | 0.00% | −1,300−13.6% | Reduced |
| UBS Group AG | 21,300 | $165.0K | 0.00% | +21,253+45,219.1% | Added |
| Geode Capital Management, LLC | 25,136 | $195.0K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 25,703 | $200.0K | 0.00% | −217,637−89.4% | Reduced |
| Sectoral Asset Management Inc | 38,198 | $297.0K | 0.05% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $337.0K | 0.01% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 78,066 | $607.0K | 0.05% | 00.0% | Unchanged |
| Morgan Stanley | 103,982 | $808.0K | 0.00% | +26,373+34.0% | Added |
| Victory Capital Management Inc | 183,690 | $1.30M | 0.00% | −66,690−26.6% | Reduced |
| Sio Capital Management, LLC | 259,763 | $2.02M | 0.81% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 350,000 | $2.72M | 0.01% | −698,956−66.6% | Reduced |
| 1832 Asset Management L.P. | 734,321 | $5.63M | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $5.83M | 0.25% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 948,327 | $7.37M | 0.19% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,227,017 | $9.53M | 0.20% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12.4M | 5.88% | 00.0% | Unchanged |
| TPG GP A, LLC | 2,551,794 | $19.8M | 0.25% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $22.9M | 4.24% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,055,037 | $23.7M | 0.05% | +1,481,037+94.1% | Added |
| Canada Pension Plan Investment Board | 3,116,966 | $24.2M | 0.03% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,224,770 | $25.1M | 0.41% | 00.0% | Unchanged |
| FMR LLC | 3,250,832 | $25.3M | 0.00% | +20,866+0.6% | Added |
| Johnson & Johnson | 3,670,516 | $28.5M | 5.39% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,160−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |